Sequential vs. Standard Laser Treatment of Twin-twin Transfusion Syndrome

Twin Twin Transfusion Syndrome Clinical Trial

Official title: USFetus Randomized Clinical Trial: Sequential vs. Standard Laser Treatment of Twin-twin Transfusion Syndrome

Status Active, not recruiting

Clinical Trial Summary

The investigators hypothesize that treatment of twin-twin transfusion syndrome (TTTS) using sequential laser photocoagulation of communicating vessels (SQLPCV) over the predominant method, selective laser photocoagulation of communicating vessels (SLPCV), may provide vascular stability to the donor fetus. The primary objective is to evaluate the perinatal outcome, specifically, donor intrauterine survival of TTTS managed by SQLPCV vs. SLPCV in a prospective, randomized trial.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Fetofetal Transfusion
• Syndrome
• Twin Twin Transfusion Syndrome

• NCT number: NCT02122328
• Study type: Interventional
• Source: University of Southern California
• Status: Active, not recruiting
• Phase: N/A
• Start date: June 9, 2010
• Completion date: May 30, 2024